Market revenue in 2023 | USD 276.3 million |
Market revenue in 2030 | USD 741.8 million |
Growth rate | 15.2% (CAGR from 2023 to 2030) |
Largest segment | Serum-free media |
Fastest growing segment | Serum-free Media |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH |
Serum-free media was the largest segment with a revenue share of 35.29% in 2023. Horizon Databook has segmented the South Korea cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
The Pharmaceutical Affairs Act is the main legislation that the Ministry of Food and Drug Safety uses to govern cellular therapy products (PAA). Cell therapy products are considered biologic products under the PAA. The regulatory framework for biologic goods is described in depth through seven rules and eight guidelines. The Regulation on Investigation New Drug Application for Medicinal Products and Regulation on Review and Authorization of Biological Products are the two main regulations that offer marketing authorization for biologic products.
Minimally altered cellular remedies developed by research institutions and human tissue regulated under the Human Tissue Safety and Control Act are the two exclusions to PAA biologic product regulations. Moreover, the Bioethics Act regulates research on embryonic stem cells and implementation of in vitro fertilization. Several South Korean bioethical policies are based on this act and it has also played a central role in the establishment of the National Bioethics Committee, which oversees stem cell research in South Korea.
Similarly, two other organizations, the Ministry of Health and Welfare and the World Stem Cell Hub at Seoul National University, have outlined guidelines for management of stem cells in the country. Furthermore, the National Bioethics Committee is the central organization that addresses the Bioethics Act and reviews bioethics policies in South Korea.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account